Park Kimberly

SEC Form 4 insider trading activity

Park Kimberly has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.

On the most recent filing, Park Kimberly is listed as Director at CORCEPT THERAPEUTICS INC. Inside the rolling window, Park Kimberly reported no open-market purchases and 1 open-market sale totaling $3.3M in CORT.

Companies traded

Other insiders at CORT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$3.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CORT
Park Kimberly
Sale$3.3MAug 28SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Park Kimberly made?

Park Kimberly has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.

Which companies does Park Kimberly trade?

Park Kimberly has filed SEC Form 4 disclosures for 1 company, including CORT.

When was Park Kimberly's most recent SEC Form 4 filing?

Park Kimberly's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.

What is Park Kimberly's total buy and sell value in the current window?

Inside the rolling retention window, Park Kimberly bought $0 and sold $3.3M based on SEC Form 4 filings.

What was Park Kimberly's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 26,685 CORT shares on 2026-08-26, worth $3.3M, per SEC Form 4 filings.